179 related articles for article (PubMed ID: 34285483)
1. Urinary Exosomal CA9 mRNA as a Novel Liquid Biopsy for Molecular Diagnosis of Bladder Cancer.
Wen J; Yang T; Mallouk N; Zhang Y; Li H; Lambert C; Li G
Int J Nanomedicine; 2021; 16():4805-4811. PubMed ID: 34285483
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Derived Exosomal RNA From Fine-Needle Aspiration Supernatant as a Novel Liquid Biopsy for Molecular Diagnosis of Cancer.
Li G; Liu D; Flandrin P; Zhang Y; Lambert C; Mallouk N; Cottier M
Pathol Oncol Res; 2022; 28():1610344. PubMed ID: 35991837
[No Abstract] [Full Text] [Related]
3. Urinary exosomal mRNA as a biomarker for the diagnosis of bladder cancer.
Wang X; Song D; Zhu B; Jin Y; Cai C; Wang Z
Anticancer Drugs; 2024 Apr; 35(4):362-370. PubMed ID: 38385960
[TBL] [Abstract][Full Text] [Related]
4. Exosomes expressing carbonic anhydrase 9 promote angiogenesis.
Horie K; Kawakami K; Fujita Y; Sugaya M; Kameyama K; Mizutani K; Deguchi T; Ito M
Biochem Biophys Res Commun; 2017 Oct; 492(3):356-361. PubMed ID: 28851650
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.
Urquidi V; Goodison S; Kim J; Chang M; Dai Y; Rosser CJ
Urology; 2012 May; 79(5):1185.e1-6. PubMed ID: 22386755
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
[TBL] [Abstract][Full Text] [Related]
7. Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis.
Wang J; Yang K; Yuan W; Gao Z
Med Sci Monit; 2018 Dec; 24():9307-9316. PubMed ID: 30576305
[TBL] [Abstract][Full Text] [Related]
8. Presence of Urinary Exosomes for Liquid Biopsy of Clear Cell Renal Cell Carcinoma: Protocol for a Pilot Feasibility Study.
Li G; Mallouk N; Flandrin P; Garcin A; Lambert C; Berremila SA; Habchi H; Mottet N
JMIR Res Protoc; 2021 Jul; 10(7):e24423. PubMed ID: 34283029
[TBL] [Abstract][Full Text] [Related]
9. The value of urinary exosomal lncRNA SNHG16 as a diagnostic biomarker for bladder cancer.
Liu C; Xu P; Shao S; Wang F; Zheng Z; Li S; Liu W; Li G
Mol Biol Rep; 2023 Oct; 50(10):8297-8304. PubMed ID: 37592177
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy biomarkers of renal interstitial fibrosis based on urinary exosome.
Chun-Yan L; Zi-Yi Z; Tian-Lin Y; Yi-Li W; Bao L; Jiao L; Wei-Jun D
Exp Mol Pathol; 2018 Oct; 105(2):223-228. PubMed ID: 30121168
[TBL] [Abstract][Full Text] [Related]
11. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z
Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma.
Todenhöfer T; Gibb EA; Seiler R; Kamyabi A; Hennenlotter J; McDonald P; Moskalev I; Stewart C; Gao J; Fazli L; Dedhar S; Stenzl A; Oo HZ; Black PC
Urol Oncol; 2021 Aug; 39(8):498.e1-498.e11. PubMed ID: 34083096
[TBL] [Abstract][Full Text] [Related]
13. Urinary carbonic anhydrase IX splicing messenger RNA variants in urogenital cancers.
Malentacchi F; Vinci S; Melina AD; Kuncova J; Villari D; Nesi G; Selli C; Orlando C; Pazzagli M; Pinzani P
Urol Oncol; 2016 Jul; 34(7):292.e9-292.e16. PubMed ID: 27005925
[TBL] [Abstract][Full Text] [Related]
14. Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker.
Piao XM; Cha EJ; Yun SJ; Kim WJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567779
[TBL] [Abstract][Full Text] [Related]
15. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
Zhan Y; Du L; Wang L; Jiang X; Zhang S; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Wang C
Mol Cancer; 2018 Sep; 17(1):142. PubMed ID: 30268126
[TBL] [Abstract][Full Text] [Related]
16. Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
Güllü Amuran G; Tinay I; Filinte D; Ilgin C; Peker Eyüboğlu I; Akkiprik M
Int Urol Nephrol; 2020 Mar; 52(3):461-468. PubMed ID: 31679136
[TBL] [Abstract][Full Text] [Related]
17. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy.
Feng Y; Lv LL; Wu WJ; Li ZL; Chen J; Ni HF; Zhou LT; Tang TT; Wang FM; Wang B; Chen PS; Crowley SD; Liu BC
Am J Pathol; 2018 Nov; 188(11):2542-2552. PubMed ID: 30142333
[TBL] [Abstract][Full Text] [Related]
18. A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis.
Lv CY; Ding WJ; Wang YL; Zhao ZY; Li JH; Chen Y; Lv J
Int Urol Nephrol; 2018 May; 50(5):973-982. PubMed ID: 29330775
[TBL] [Abstract][Full Text] [Related]
19. Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.
El-Shal AS; Shalaby SM; Abouhashem SE; Elbary EHA; Azazy S; Rashad NM; Sarhan W
Mol Biol Rep; 2021 May; 48(5):4361-4371. PubMed ID: 34085193
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell Carcinoma.
Eckert AW; Horter S; Bethmann D; Kotrba J; Kaune T; Rot S; Bache M; Bilkenroth U; Reich W; Greither T; Wickenhauser C; Vordermark D; Taubert H; Kappler M
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
